Managers / Q3 2022 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Reported Value
$306M
Q3 2022
Positions
67
Filings on Record
32
2019–present window
Filed
Nov 14, 2022
original filing
Summary
Harbourvest Partners LLC reported $306M in U.S.-listed holdings across 67 positions for Q3 2022.
Its largest position, TOST, represents 12.5% of the portfolio.
Compared with Q2 2022, the fund opened 7 new positions and exited 2.
Portfolio Metrics
Turnover
+15.2%
vs prior filed quarter
Top-10 Concentration
+73.8%
share of reported value
Largest Position
+12.5%
Toast
New / Exited
7 / 2
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 84.2% · $257M
- Other · 13.7% · $42M
- ADR · 2.1% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GTMZoom Information, Inc | NEW | +272.6K | 272.6K | +$11M | $11M |
| PAYOPayoneer, Inc | NEW | +420.6K | 420.6K | +$3M | $3M |
| PLRXPliant Therapeutics, Inc | NEW | +64.8K | 64.8K | +$1M | $1M |
| RVMDRevolution Medicines | NEW | +44.0K | 44.0K | +$869,000 | $869,000 |
| SMRTSmartRent.com | NEW | +220.3K | 220.3K | +$500,000 | $500,000 |
| GTLBGitlab Inc. | NEW | +6.2K | 6.2K | +$317,000 | $317,000 |
| GreenLight Biosciences, Inc. | NEW | +48.8K | 48.8K | +$113,000 | $113,000 |
| HashiCorp, Inc. | SOLD OUT | −231.3K | 0 | −$7M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
67 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TOSTToast, Inc.history → | Common CLA | 12.48% | $38M | 2.28M |
| 2 | WWayfair Inc.history → | Common CLA | 11.30% | $35M | 1.06M |
| 3 | NABLN-Able, Inc.history → | Common | 11.22% | $34M | 3.72M |
| 4 | Solarwinds Corp. | Common | 9.42% | $29M | 3.72M |
| 5 | AVDXAvidXchange Holdings, Inc.history → | Common | 9.33% | $29M | 3.39M |
| 6 | MNDYmonday.com Ltd.history → | SHS | 6.74% | $21M | 182.0K |
| 7 | Omega Therapeutics, Inc. | Common | 4.69% | $14M | 2.65M |
| 8 | GTMZoom Information, Inchistory → | Common | 3.71% | $11M | 272.6K |
| 9 | Axcella Health, Inc. | Common | 2.45% | $7M | 4.38M |
| 10 | Sonder Holdings, Inc. | Common CLA | 2.44% | $7M | 4.50M |
| 11 | RLAYRelay Therapeutics, Inc.history → | Common | 2.17% | $7M | 296.4K |
| 12 | Evelo Biosciences, Inc. | Common | 2.09% | $6M | 3.06M |
| 13 | YMMFull Truck Alliance Co. Ltd.history → | ADR | 2.05% | $6M | 957.6K |
| 14 | LendingClub Corp. | Common | 1.85% | $6M | 513.4K |
| 15 | Bright Health Group, Inc. | Common | 1.45% | $4M | 4.22M |
| 16 | FTCHQFarfetch Ltd.history → | Ordinary Shares CLA | 1.08% | $3M | 442.7K |
| 17 | BEBloom Energy Corporationhistory → | Common CLA | 1.06% | $3M | 162.2K |
| 18 | Squarespace, Inc. | Class A | 0.97% | $3M | 138.8K |
| 19 | Inari Medical | Common | 0.92% | $3M | 38.5K |
| 20 | PAYOPayoneer, Inc | Common | 0.83% | $3M | 420.6K |
| 21 | AMPLAmplitude Inc. | Common CLA | 0.77% | $2M | 153.0K |
| 22 | IASIntegral Ad Science, Inc. | Common | 0.72% | $2M | 305.3K |
| 23 | IBRXImmunityBio, Inc. | Common | 0.55% | $2M | 335.7K |
| 24 | HNSTThe Honest Company Inc. | Common | 0.54% | $2M | 475.6K |
| 25 | DOCNDigital Ocean, Inc. | Common | 0.52% | $2M | 44.2K |
| 26 | DOCSDoximity, Inc. | Common CLA | 0.49% | $2M | 49.8K |
| 27 | Olo, Inc. | Common CLA | 0.49% | $1M | 188.3K |
| 28 | SPOTSpotify Technology S.A. | SHS | 0.47% | $1M | 16.8K |
| 29 | PLRXPliant Therapeutics, Inc | Common | 0.44% | $1M | 64.8K |
| 30 | FROGJfrog Ltd. | ORD SHS | 0.43% | $1M | 59.0K |
| 31 | DIBS1stdibs.com, Inc. | Common | 0.41% | $1M | 199.5K |
| 32 | Zuora, Inc. | Common | 0.40% | $1M | 163.9K |
| 33 | PGNYProgyny, Inc. | Common | 0.39% | $1M | 31.9K |
| 34 | COURCoursera, Inc. | Common | 0.37% | $1M | 106.1K |
| 35 | UUnity Software | Common | 0.36% | $1M | 34.2K |
| 36 | ACVAACV Auctions, Inc. | Common CLA | 0.35% | $1M | 147.1K |
| 37 | TWLOTwilio, Inc. | Common CLA | 0.33% | $1M | 14.6K |
| 38 | Starry Holdings, Inc. | Common CLA | 0.32% | $993,000 | 666.7K |
| 39 | ONTFON24, Inc. | Common | 0.31% | $961,000 | 109.2K |
| 40 | Sumo Logic, Inc. | Common | 0.31% | $958,000 | 127.8K |
| 41 | RVMDRevolution Medicines | Common | 0.28% | $869,000 | 44.0K |
| 42 | PATHUiPath, Inc. | Common CLA | 0.26% | $803,000 | 63.7K |
| 43 | Eventbrite, Inc. | Common CLA | 0.20% | $621,000 | 102.2K |
| 44 | HOODRobinhood Markets Inc. | Common CLA | 0.17% | $512,000 | 50.7K |
| 45 | SMRTSmartRent.com | Common CLA | 0.16% | $500,000 | 220.3K |
| 46 | PINSPinterest, Inc. | Common CLA | 0.16% | $497,000 | 21.3K |
| 47 | CPNGCoupang Inc. | Common CLA | 0.15% | $447,000 | 26.8K |
| 48 | AFRMAffirm, Inc. | Common CLA | 0.14% | $435,000 | 23.2K |
| 49 | Rubius Therapeutics, Inc. | Common | 0.14% | $428,000 | 986.9K |
| 50 | FLYWFlywire Corporation | Common Voting | 0.13% | $394,000 | 17.2K |
| 51 | Sigilon Therapeutics, Inc. | Common | 0.12% | $374,000 | 740.7K |
| 52 | GTLBGitlab Inc. | Common CLA | 0.10% | $317,000 | 6.2K |
| 53 | Seres Therapeutics, Inc. | Common | 0.10% | $317,000 | 49.4K |
| 54 | IPSCCentury Therapeutics, Inc. | Common | 0.09% | $287,000 | 29.0K |
| 55 | QSQuantumScape Corporation | Common CLA | 0.08% | $243,000 | 29.0K |
| 56 | Spark Networks SE | Sponsored ADR | 0.07% | $199,000 | 104.2K |
| 57 | Duck Creek Technologies, Inc. | SHS | 0.06% | $172,000 | 14.5K |
| 58 | RPTXRepare Therapeutics, Inc. | Common | 0.05% | $149,000 | 12.3K |
| 59 | OPENOpendoor Technologies Inc. | Common | 0.05% | $145,000 | 46.7K |
| 60 | PMVPPMV Pharmaceuticals | Common | 0.04% | $137,000 | 11.5K |
| 61 | PACBPacific Biosciences of California, Inc. | Common | 0.04% | $136,000 | 23.5K |
| 62 | DASHDoorDash, Inc. | Common CLA | 0.04% | $124,000 | 2.5K |
| 63 | Astra Space, Inc. | Common CLA | 0.04% | $114,000 | 186.7K |
| 64 | GreenLight Biosciences, Inc. | Common | 0.04% | $113,000 | 48.8K |
| 65 | OYSTOyster Point Pharma, Inc. | Common | 0.02% | $71,000 | 12.6K |
| 66 | NextCure, Inc. | Common | 0.01% | $28,000 | 10.0K |
| 67 | Aligos Therapeutics, Inc. | Common | 0.01% | $21,000 | 18.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.